National Institute on Aging; Notice of Closed Meetings, 34260 [2024-09179]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
34260
Federal Register / Vol. 89, No. 84 / Tuesday, April 30, 2024 / Notices
Who is Eligible: Nominations are
encouraged for new or reappointment of
non-Federal public members who can
provide the public and/or patient
perspectives to discussions of issues
considered by the Committee. Selfnominations and nominations of other
individuals are both permitted. Only
one nomination per individual is
required. Multiple nominations for the
same individual will not increase
likelihood of selection. Non-Federal
public members may be selected from
the pool of submitted nominations or
other sources as needed to meet
statutory requirements and to form a
balanced committee that represents the
diversity within the muscular dystrophy
communities. Nominations are
especially encouraged from leaders or
representatives of muscular dystrophy
research, advocacy, or service
organizations, as well as individuals
with muscular dystrophy or their
parents or guardians. In accordance
with White House Office of
Management and Budget guidelines (FR
Doc. 2014–19140), federally-registered
lobbyists are not eligible.
Committee Composition: The
Department strives to ensure that the
membership of HHS Federal advisory
committees is fairly balanced in terms of
points of view represented and the
committee’s function. Every effort is
made to ensure that the views of all
genders, all ethnic and racial groups,
and people with disabilities are
represented on HHS Federal advisory
committees and, therefore, the
Department encourages nominations of
qualified candidates from these groups.
The Department also encourages
geographic diversity in the composition
of the Committee. Appointment to this
Committee shall be made without
discrimination on the basis of age, race,
ethnicity, gender, sexual orientation,
disability, and cultural, religious, or
socioeconomic status. Requests for
reasonable accommodation to enable
participation on the Committee should
be indicated in the nomination
submission.
Member Terms: Non-Federal public
members of the Committee serve for a
term of three years and may serve for an
unlimited number of terms if
reappointed. Members may serve after
the expiration of their terms, until their
successors have taken office.
Meetings and Travel: As specified by
Public Law 113–166, the MDCC ‘‘shall
meet no fewer than two times per
calendar year.’’ Travel expenses are
provided for non-Federal public
Committee members to facilitate
attendance at in-person meetings.
Members are expected to make every
VerDate Sep<11>2014
17:27 Apr 29, 2024
Jkt 262001
effort to attend all full committee
meetings, twice per year, either in
person or via remote access.
Participation in relevant subcommittee,
working and planning group meetings,
and workshops, is also encouraged.
Submission Instructions and
Deadline: Nominations are due by 5:00
p.m. ET on May 31, 2024, and should
be sent to Glen Nuckolls, Ph.D., by
email to nuckollg@ninds.nih.gov.
Nominations must include contact
information for the nominee, a current
curriculum vitae or resume of the
nominee, and a paragraph describing
the qualifications of the person to
represent some portion(s) of the
muscular dystrophy research, advocacy,
and/or patient care communities.
More information about the MDCC is
available at https://mdcc.nih.gov/.
Dated: April 24, 2024.
Walter J. Koroshetz,
Director, National Institute of Neurological
Disorders and Stroke, National Institutes of
Health.
[FR Doc. 2024–09303 Filed 4–29–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Dementia
Caregiver Support Intervention.
Date: May 24, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sandhya Sanghi, Ph.D.,
Scientific Review Officer, National Institutes
of Health, National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue
(2N230), NIA/SRB, Bethesda, MD 20892,
(301) 496–2879, sandhya.sanghi@nih.gov.
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
Name of Committee: National Institute on
Aging Special Emphasis Panel; NIA multisite
clinical trials.
Date: May 31, 2024.
Time: 9:30 a.m. to 11:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maurizio Grimaldi, M.D.,
Ph.D., Scientific Review Officer, National
Institutes of Health, National Institute on
Aging, Gateway Building, 7201 Wisconsin
ROOM 2C218, Bethesda, MD 20892, 301–
496–9374, grimaldim2@mail.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Validation of
Analytical and Clinical Biomarkers for
ADRD.
Date: June 20, 2024.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Gianina Ramona
Dumitrescu, MPH, Ph.D., Scientific Review
Officer, National Institutes of Health,
National Institute on Aging, Gateway
Building, 7201 Wisconsin ROOM 2C218,
Bethesda, MD 20892, 301–827–4342,
ramona.dumitrescu@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: April 24, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–09179 Filed 4–29–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
[OMB Control Number 1651–0123]
Agency Information Collection
Activities; Revision; Regulations
Relating to Copyrights and
Trademarks
U.S. Customs and Border
Protection (CBP), Department of
Homeland Security.
ACTION: 30-Day notice and request for
comments.
AGENCY:
The Department of Homeland
Security, U.S. Customs and Border
Protection (CBP) will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995 (PRA). The
information collection is published in
SUMMARY:
E:\FR\FM\30APN1.SGM
30APN1
]]>Agencies
[Federal Register Volume 89, Number 84 (Tuesday, April 30, 2024)]
[Notices]
[Page 34260]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-09179]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Aging Special Emphasis
Panel; Dementia Caregiver Support Intervention.
Date: May 24, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sandhya Sanghi, Ph.D., Scientific Review
Officer, National Institutes of Health, National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue (2N230), NIA/SRB, Bethesda,
MD 20892, (301) 496-2879, [email protected].
Name of Committee: National Institute on Aging Special Emphasis
Panel; NIA multisite clinical trials.
Date: May 31, 2024.
Time: 9:30 a.m. to 11:00 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maurizio Grimaldi, M.D., Ph.D., Scientific
Review Officer, National Institutes of Health, National Institute on
Aging, Gateway Building, 7201 Wisconsin ROOM 2C218, Bethesda, MD
20892, 301-496-9374, [email protected].
Name of Committee: National Institute on Aging Special Emphasis
Panel; Validation of Analytical and Clinical Biomarkers for ADRD.
Date: June 20, 2024.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Gianina Ramona Dumitrescu, MPH, Ph.D.,
Scientific Review Officer, National Institutes of Health, National
Institute on Aging, Gateway Building, 7201 Wisconsin ROOM 2C218,
Bethesda, MD 20892, 301-827-4342, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging
Research, National Institutes of Health, HHS)
Dated: April 24, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-09179 Filed 4-29-24; 8:45 am]
BILLING CODE 4140-01-P
